Biomarin Pharmaceutical (BMRN) Amortization - Intangibles: 2009-2025
Historic Amortization - Intangibles for Biomarin Pharmaceutical (BMRN) over the last 14 years, with Sep 2025 value amounting to $4.8 million.
- Biomarin Pharmaceutical's Amortization - Intangibles fell 3.23% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.2 million, marking a year-over-year decrease of 50.47%. This contributed to the annual value of $43.3 million for FY2024, which is 30.47% down from last year.
- Biomarin Pharmaceutical's Amortization - Intangibles amounted to $4.8 million in Q3 2025, which was up 0.02% from $4.8 million recorded in Q2 2025.
- Over the past 5 years, Biomarin Pharmaceutical's Amortization - Intangibles peaked at $17.7 million during Q1 2021, and registered a low of $4.8 million during Q2 2025.
- For the 3-year period, Biomarin Pharmaceutical's Amortization - Intangibles averaged around $10.9 million, with its median value being $14.3 million (2024).
- As far as peak fluctuations go, Biomarin Pharmaceutical's Amortization - Intangibles increased by 18.64% in 2021, and later slumped by 68.06% in 2024.
- Biomarin Pharmaceutical's Amortization - Intangibles (Quarterly) stood at $17.3 million in 2021, then fell by 5.94% to $16.3 million in 2022, then fell by 6.29% to $15.2 million in 2023, then slumped by 36.66% to $9.7 million in 2024, then decreased by 3.23% to $4.8 million in 2025.
- Its Amortization - Intangibles stands at $4.8 million for Q3 2025, versus $4.8 million for Q2 2025 and $4.8 million for Q1 2025.